본문으로 건너뛰기
← 뒤로

The integration of gene mutations and copy number variations refines the prognosis of mantle cell lymphoma: long-term results of the Fondazione Italiana Linfomi MCL0208 clinical trial.

Leukemia 2026 Vol.40(1) p. 219-223

Moia R, Ragaini S, Cascione L, Rinaldi A, Genuardi E, Talotta D, Almasri M, Bruscaggin A, Zaccaria GM, Evangelista A, Civita AM, Di Rocco A, Petrucci L, Cavallo F, Celli M, Luppi M, Stelitano C, Stefani PM, Visco C, Billio A, Casaroli I, Castellino C, Pavone E, Galimberti S, Plenteda C, Merli F, Mahmoud AM, Rossi D, Gaidano G, Ladetto M, Bertoni F, Ferrero S

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Moia R, Ragaini S, et al. (2026). The integration of gene mutations and copy number variations refines the prognosis of mantle cell lymphoma: long-term results of the Fondazione Italiana Linfomi MCL0208 clinical trial.. Leukemia, 40(1), 219-223. https://doi.org/10.1038/s41375-025-02795-0
MLA Moia R, et al.. "The integration of gene mutations and copy number variations refines the prognosis of mantle cell lymphoma: long-term results of the Fondazione Italiana Linfomi MCL0208 clinical trial.." Leukemia, vol. 40, no. 1, 2026, pp. 219-223.
PMID 41204002